Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000812253 | SCV000952561 | uncertain significance | Immunodeficiency 23 | 2021-08-31 | criteria provided, single submitter | clinical testing | This sequence change replaces phenylalanine with leucine at codon 407 of the PGM3 protein (p.Phe407Leu). The phenylalanine residue is highly conserved and there is a small physicochemical difference between phenylalanine and leucine. This variant is present in population databases (rs774568856, ExAC 0.003%). This missense change has been observed in individual(s) with congenital disorders of glycosylation (CDGs) (PMID: 28543917). It has also been observed to segregate with disease in related individuals. This variant is also known as p.Phe379Leu. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Blueprint Genetics | RCV001597218 | SCV001832379 | likely pathogenic | not provided | 2019-11-30 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000812253 | SCV003814915 | uncertain significance | Immunodeficiency 23 | 2021-08-26 | criteria provided, single submitter | clinical testing |